Ophthalmology company Rodenstock, a portfolio company of Compass Partners, has announced the completion of an equity capital increase of up to €75m from its existing investors.
Ophthalmology company Rodenstock, a portfolio company of Compass Partners, has announced the completion of an equity capital increase of up to €75m from its existing investors.